ACIP review of the hepatitis B birth dose vaccination remains a grave concern - Please read more here.

Site Search

You searched for "hepatitis D"

  • Journey to the Cure: What Does Liver Cancer Research Look Like? ft. Aejaz Sayeed, PhD

    Welcome to “Journey to the Cure.” This is a web series that chronicles the progress at the Hepatitis B Foundation and Baruch S. Blumberg Institute towards finding the cure for hepatitis B. In the fourth episode (part 2), Kristine Alarcon, MPH sits down with Aejaz Sayeed, PhD, Assistant Professor at the Baruch S. Blumberg Institute, to talk about his research in liver cancer. For any questions about hepatitis B, please email info@hepb.org. Disclaimer: The information provided in this audio post is not intended to serve as medical advice of endorsement of any product. The Hepatitis B Foundation strongly recommends each person discuss this information and their questions with a qualified health care provider. Edited by: Kristine Alarcon, MPH Special thanks: Samantha Young Music: Modern – iMovie Library Collection Script: Welcome to “Journey to the Cure!” Every month, we’ll sit down with scientists from the Hepatitis B Foundationand the Baruch S. Blumberg Instituteto talk to you about hepatitis B and efforts to find a cure for hepatitis B. There’s still a long way to go, but we’re here to walk you through our journey. Kristine Alarcon, MPH: Can you tell me about your research? Aejaz Sayeed, PhD: That’s an interesting question. I’vespent a lot of time pursuing breast cancer and prostate cancer. I just started working on the liver cancer. There are millions of people who are pursuing cancer research, but the challenge is that we have done a lot of progress in some cancers, but some cancers, still, we do not have a handle on. For example, we have done a lot of progress in breast and prostate cancer. We have not done much in pancreatic and liver cancer. And, the five-year survival rates of breast and prostate and other cancers have drastically increased, but we have not done much of a progress in pancreatic or a specific form of brain cancer or pancreatic cancer or liver cancer. The problem, again, is that we’re not able to detect the disease at an

    http://www.hepb.org/blog/journey-cure-liver-cancer-research-look-like-ft-aejaz-sayeed-phd/
  • Newly Diagnosed with Hepatitis B? How Did I Get this? Learning the HBV Transmission Basics

    If you have just been diagnosed with hepatitis B virus (HBV) then you need to understand how HBV is transmitted. This is important whether you have an acute or chronic infection.  You must understand you are infectious and can transmit the virus to others. How is hepatitis B transmitted? Hepatitis B is transmitted through direct contact with infected blood or certain bodily fluids. The virus is most commonly transmitted from an infected pregnant person to their baby during childbirth, due to the blood exchange that happens between mother and baby. It is also transmitted through unsterile medical or dental equipment, unprotected sex, or unsterile needles. For kids, pediatric experts report that the fluid that oozes from cuts and open sores is also highly infectious, so keep those open cuts covered. Hepatitis B can also be transmitted inadvertently by the sharing of personal items such as razors, toothbrushes, nail clippers, body jewelry and other personal items that have small amounts of blood on them. Hepatitis B is not transmitted casually by sneezing or coughing, shaking hands, hugging or sharing or preparing a meal. In fact, the virus is not contracted during most of life’s daily activities. You don’t need to keep cups, bowls, plates or utensils separate. Hugging, or even kissing won’t cause infection unless there are bleeding gums or open sores during the exchange. It’s really all about trace amounts of infected blood, though the virus is in other bodily fluids in lower concentrations. For example, it’s not the saliva on the toothbrush that is a big concern, but rather the potential for trace amounts of blood that could be exchanged with a shared toothbrush. How did I get this? If you have been diagnosed with hepatitis B virus you are likely racking your brain trying to figure out how you could have gotten HBV.  Some can immediately track their likely exposure to a recent event, or perhaps a time period in their life where they were more likely to

    https://www.hepb.org/blog/newly-diagnosed-with-hepatitis-b-how-did-i-get-this-learning-the-hbv-basics-transmission-part-i/
  • Journey to the Cure: How is Hepatitis B Related to Liver Cancer ft. Aejaz Sayeed, PhD

    Welcome to “Journey to the Cure.” This is a web series that chronicles the progress at the Hepatitis B Foundation and Baruch S. Blumberg Institute towards finding the cure for hepatitis B. In the four episode (part 1), Kristine Alarcon, MPH talks with Aejaz Sayeed, PhD, Assistant Professor of the Baruch S. Blumberg Institute. They talk about how hepatitis B is connected to liver cancer and doctors and scientists tell if a patient has cancer. For any questions about hepatitis B, please email info@hepb.org. The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure and improving the lives of those affected by hepatitis B worldwide through research, education and patient advocacy. Visit us at www.hepb.org, on Facebook at www.facebook.com/hepbfoundation, on Twitter at @hepbfoundation, and our Blog at www.hepb.org/blog Disclaimer: The information provided in this video is not intended to serve as medical advice or endorsement of any product. The Hepatitis B Foundation strongly recommends each person discuss this information and their questions with a qualified health care provider. Edited: Kristine Alarcon, MPH Special thanks: Samantha Young Music: Modern - iMovie Library Collection    

    http://www.hepb.org/blog/journey-cure-hepatitis-b-related-liver-cancer-ft-aejaz-sayeed-phd/
  • Finding the Missing Millions in Ghana

    Theobald Owusu-Ansah, President of the Hepatitis Foundation of Ghana and Hepatitis Coalition of Ghana and Guest Blogger, shares his efforts to eliminate hepatitis B in Ghana. Viral Hepatitis is very common in Ghana, but awareness and testing has remained low. The Hepatitis Foundation of Ghana is working hard to address these gaps. Our mission is to eliminate viral hepatitis and improve the quality of life for those living with chronic hepatitis B and C in Ghana. We have a robust viral hepatitis community screening and awareness program. Through this program, we are working to reduce hepatitis B and C transmission among people in Agona, a farming community in the Nzema East Municipality of the Western region, Ketu South of the Volta Region, Kumasi in the Ashanti Region and Sekondi Komfoase and Takoradi in the Western; and also raise awareness on viral hepatitis infection, reducing stigma and discrimination through free screening, vaccination and education activities. Since this program started, we have made great progress towards these goals! Read on to learn about our most recent successes: EVENT AT AGONA ON 22ND DECEMBER, 2017 The Hepatitis Foundation of Ghana held a free hepatitis B screening, education and community gathering in Agona, a farming community in the Nzema East Municipality of the Western region A total of 101 persons were screened for hepatitis B. In all, 6 people tested positive for hepatitis B. Those who tested positive were counselled and referred to the district hospital for proper care and treatment. EVENT AT KETU SOUTH ON 23RD DECEMBER, 2017 Hepatitis B free screening and education were held at Ketu South, a community in the Volta region. A total of 244 persons were screened for hepatitis B. In all, 6 people tested positive. They were counselled and referred to the district hospital for proper care and treatment. There have been some deaths reported within the community as a result of viral hepatitis according to the people in the community.

    http://www.hepb.org/blog/finding-missing-millions-ghana/
  • Recently Diagnosed with Hepatitis B? Getting Through the Next Months Waiting to Confirm if Your Infection is Acute or Chronic

    Have you recently been told you have hepatitis B?  Dealing with the diagnosis and waiting out the next six months to determine if your infection will resolve itself or learning that it is a chronic infection can be nerve-wracking. Fortunately, greater than 90 percent of healthy adults who are newly infected will clear or resolve an acute hepatitis B infection.  On the hand, greater than 90% of babies and up to 50% of children infected with hepatitis B will have lifelong, chronic infection. Sometimes people are surprised to learn they have a chronic infection. It can be confusing since there are typically few or no symptoms for decades. If a person continues to test hepatitis B positive for longer than 6 months, then it is considered a chronic infection. Repeat testing is the only way to know for sure. Acute hepatitis B patients rarely require hospitalization, or even medication.  If you are symptomatic, (some symptoms include jaundice, dark urine, abdominal pain, fever, general malaise)  you may be anxiously conferring with your doctor, but if you are asymptomatic, you might not feel compelled to take the diagnosis seriously.  Ignoring your diagnosis can be very serious. If you have concerning symptoms like jaundice (yellow eyes and skin), a bloated abdomen or severe nausea and vomiting, please see your doctor immediately. Your doctor will be monitoring your blood work over the next few months to see if you clear the virus, or monitoring your liver if there are concerning symptoms. Your job is to start loving your liver ...today.  STOP drinking alcoholic beverages.  Refrain from smoking cigarettes.  Your liver is a non-complaining organ, but you cannot live without it.  Make your diet liver-friendly and healthy filled with a rainbow of vegetables and fruits, whole grains, fish and lean meats. Minimize processed foods, saturated fats and sugar.  Drink plenty of water. Talk to your doctor before taking prescription medications, herbal remedies,

    http://www.hepb.org/blog/diagnosed-with-acute-hbv-getting-through-the-next-six-months/
  • Turkish

    To view or print the entire Turkish Chapter in English, as a single document click here. Turkce pdf If you do not have Adobe Acrobat Reader, download it here for free. Hepatit B Vakfı Web Sitesinin Türkçe Bölümüne Hoş Geldiniz Hepatit B sessiz bir hastalıktır ve çoğu kişi enfekte olduğunu bile bilmez. Bu web sitesi hepatit B önlenmesi, tanı konması ve takibi hakkında bilgiler içerir. Bu bilgileri arkadaşlarınız, aileniz ve toplumunuzdaki diğer kişilerle paylaşmanızı öneririz. Hepatit B hakkında bilmeniz gereken bazı önemli şeyler şunlardır: • Hepatit B kalıtsal değildir ve nedeni bir virüstür. 
• Sizi ömür boyu hepatit B'den koruyacak güvenli bir aşı vardır. 
• Hepatit B tanısını koymak için basit bir kan testi vardır. 
• Tedavi seçenekleri mevcuttur. Hepatit B Küresel bir HastalıktırHepatit B her yaş ve etnik kökenden kişileri enfekte edebilir ama dünyada hepatit B'nin daha sık görüldüğü yerler mevcuttur: örneğin Asya, Afrika ve Güney Amerika'nın bazı kısımları, Doğu Avrupa ve Orta Doğu'daki kişilerin enfekte olma riski çok daha yüksektir. Hepatit B bu bölgelerde doğan Amerikalılar (veya ebeveynleri buralarda doğmuş olanlar) arasında da sıktır. Dünya çapında hepatit B hastalığı olan yüzlerce milyon kişi vardır. Çoğu kişi enfekte olduğunu bilmez ve bir belirtisi yoktur – ama bilmeniz gereken birçok önemli şey bulunmaktadır. Hepatit B testi yaptırmanız yaşamınızı kurtarabilir. Hepatit B durumunuz olduğunu biliyorsanız karaciğerinizi sağlıklı tutmak için yaşam tarzı değişiklikleri yapabilir ve virüsü takip edip karaciğer hasarını önlemesi için bir doktoru görebilirsiniz. Hepatit B Vakfı, araştırma, eğitim ve hasta hakları savunuculuğu yoluyla dünya çapında hepatit B'den etkilenmiş herkes için tam bir tedavi bulmak ve yaşam kalitesini arttırmak amaçlı ulusal ve kar amacı gütmeyen bir örgüttür. Red Beyanı: Bu web sitesinde sağlanan bilgi sadece eğitim amacıyladır. Hepatit B Vakfı tıbbi bir örgüt değildir. Lütfen kişisel tıbbi bakım ve öneriler için doktorunuz veya vasıflı bir sağlık uzmanıyla konuşun. Welcome to the Turkish Chapter of the Hepatitis B Foundation Website Hepatitis B is known as a silent disease, and most people don’t even know they are infected. This website contains information about preventing, diagnosing and managing hepatitis B. We encourage you to share this information with your friends, family and others in your community. Here are some important things to remember about hepatitis B: • Hepatitis B is not inherited - it is caused by a virus. 
• There is a safe vaccine which will protect you from hepatitis B for life. 
• There is a simple blood test to diagnose hepatitis B. 
• There are treatment options. Hepatitis B is a Global DiseaseHepatitis B can infect any person of any age or ethnicity, but people from parts of the world where hepatitis B is common, such as Asia, parts of Africa and South America, Eastern Europe, and the Middle East, are at much higher risk for getting infected. Hepatitis B is also common among Americans who were born (or whose parents were born) in these regions. There are hundreds of millions of people worldwide who have hepatitis B. Most people don’t even know they are infected, and don’t have symptoms – but there are many important things you should know. Getting tested for hepatitis B can save your life. If you know you have hepatitis B, you can make lifestyle choices to keep your liver healthy and you can see a doctor to help manage the virus and prevent liver damage. The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure and helping to improve the quality of life for all those affected by hepatitis B worldwide through research, education and patient advocacy. Disclaimer: The information that is provided on this website is for educational purposes only. The Hepatitis B Foundation is not a medical organization. Please talk to your doctor or a qualified health care provider for personal medical care and advice.

    https://www.hepb.org/languages/turkish/
  • Hepatitis B Foundation applauds HHS letter on discrimination against people living with hepatitis B who are pursuing careers in health care

    Doylestown, Pa., Nov. 6, 2020 -- The Hepatitis B Foundation applauds the U.S. Department of Health and Human Services (HHS) for issuing a letter to health professions schools in the U.S., calling for renewed attention to admissions and clinical placement policies and their obligation to comply with federal civil rights laws that protect the rights of people living with hepatitis B.  In the U.S., an estimated 2.2 million people are living with chronic hepatitis B infection. Stigma and discrimination related to hepatitis B are often caused by lack of public awareness and fears and misconceptions about the disease. Students living with hepatitis B seeking education and training to become health care providers often face discriminatory admission policies and practices.  The recent letter from Admiral Brett P. Giroir, assistant secretary for health, and Roger Severino, director of the HHS Office for Civil Rights, highlights current recommendations from the U.S. Centers for Disease Control and Prevention (CDC) for hepatitis B-infected health care providers and students. Those recommendations state, “HBV [hepatitis B] infection alone should not disqualify infected persons from the practice or study of surgery, dentistry, medicine, or allied health fields.” Director Severino added, “Because stigma attached to a disability can result in discriminatory exclusion, this is an important reminder about people’s rights and provider’s responsibilities under the law.” The message also reemphasizes nondiscrimination policies, including the Americans with Disabilities Act (ADA), Section 504 of the Rehabilitation Act, and Section 1557 of the Affordable Care Act, which prohibit discrimination against people living with hepatitis B. “This message from HHS leadership brings much-needed national attention to the continued discrimination students living with hepatitis B face,” Chari Cohen, DrPH, MPH, senior vice president of the Hepatitis B Foundation, said. “Despite federal protections, we continue to receive phone calls and letters from students around the country who face unjustified denial of school admission and enrollment or dismissal from academic programs because of their hepatitis B infection.” "The Hepatitis B Foundation, which has been fighting for the rights of people living with hepatitis B for nearly 30 years, is very pleased to have this new tool that will help students and health providers facing discrimination," Dr. Cohen said. "We are grateful to Admiral Giroir and Director Severino for prioritizing the rights of people living with hepatitis B." Discriminatory admissions policies at health care profession schools were revealed in 2011 when two students contacted the Hepatitis B Foundation for assistance when they were denied admission to medical schools because they had hepatitis B. The Foundation then alerted the U.S. Department of Justice, CDC and HHS, and helped coordinate the response that ultimately led to an agreement that people living with hepatitis B deserve protection under the ADA. In 2013, with support from and in collaboration with HHS and the U.S. Department of Education, a landmark settlement by the U.S. Department of Justice ruled the medical school had violated the Americans with Disabilities Act. The Hepatitis B Foundation encourages persons living with hepatitis B who experience discrimination at a school in the U.S. to file a complaint with the HHS Office for Civil Rights. Additional resources, including guidance for health profession schools to assess and create policies and practices that adhere to CDC recommendations and legal requirements are available here. Updated 11/09/20

    https://www.hepb.org/news-and-events/news-2/hepatitis-b-foundation-applauds-hhs-letter-on-discrimination-against-people-living-with-hepatitis-b-who-are-pursuing-careers-in-health-care/
  • Get Involved

    It is vital that we improve hepatitis B screening and access to care in our high-risk African communities. To do this, we need to work together! Everyone has an important role to play, from community and faith leaders, to health care providers, to business owners. Here are some of the things that you can do in your own communities: For Community Leaders and Community-Based Organizations Host a community health forum on hepatitis B. You can use the CHIPO Powerpoint presentations to introduce hepatitis B as a health issue that needs to be addressed. Find a local Hep B United coalition partner that conducts community screening and education in the U.S., and talk about how you can work together to conduct community events. Start the conversation! Talk to your friends, family members and colleagues about the importance of getting tested for hepatitis B. You can use our #justB storyteller videos to help start the conversation at events – watch Bunmi’s, William's, Bright's, Adama's, and FK's stories for inspiration! You can also check out some of the stories shared by some of our Nigerian storytellers - hear from Sonia, Ismail, John, Gold, and Dayo! Advocate for increased hepatitis B testing in your local community – talk to your health department, and local, city or state government officials to let them know that hepatitis B is an important health issue. Join CHIPO! There is strength in numbers, and we welcome all who are interested in helping us improve testing and care among African communities. Email beatrice.zovich@hepb.org to join our coalition.  For Individuals Get tested for hepatitis B! If you find that you are not infected, talk to your doctor about getting the hepatitis B vaccine to protect you. Because hepatitis B is more common among African communities, it is important that people who were born in Africa, or whose parents were born in Africa, be tested for hepatitis B infection. Hepatitis B is a silent disease, and most people feel well when they are infected, even when the virus is damaging their liver. The CDC has a quick and simple risk assessment that you can take to help you figure out whether you should be tested for hepatitis B. If you find out that you are living with hepatitis B, don't be afraid! People living with hepatitis B often live long and healthy lives. Visit our Newly Diagnosed page for tips and next steps.  

    https://www.hepb.org/research-and-programs/chipo/get-involved/

  • Гепатит Б Сангийн вэб хуудасны Монгол хэл дээрх хувилбарт тавтай морилно уу Гепатит Б нь чимээгүй өвчин учир ихэнх хүмүүс халдвар авснаа ч мэддэггүй. Энэхүү вэб хуудас нь гепатит Б-ээс хэрхэн урьдчилан сэргийлэх, оношлох, эмчлэх талаарх мэдээллийг өгөхөд чиглэсэн. Танаас өөрийн найз нөхөд, гэр бүл болон бусад дотны хүмүүстэйгээ уг мэдээллийг хуваалцахыг хүсье. Гепатит Б вирусын талаар зарим зайлшгүй мэдэх ёстой зүйлс: Гепатит Б вирус нь удамшдаггүй харин вирусаар үүсгэгддэг. 
 Гепатит Б вирусаас бүхий л амьдралын тань турш хамгаалах вакцин байдаг. 
 Энгийн цусны шинжилгээгээр гепатит Б вирусыг оношилж болно. 
 Эмчилгээний аргачлалууд байдаг. Гепатит Б бол дэлхий нийтийн өвчинГепатит Б нь аль ч насны ямар ч хүнд гарал угсаа хамааралгүй халдварлаж болно. Гэвч Ази, Африк болон Өмнөд Америкийн зарим хэсгүүд, Зүүн Европ, Ойрхи Дорнодын улс орнуудад нийтлэг ажиглагддаг бөгөөд халдварлах магадлал ч өндөр байдаг. Түүнчлэн Гепатит Б нь өөрөө болон эцэг эх нь тус бүс нутгуудад төрсөн Америкчуудын дунд нийтлэг ажиглагддаг. Дэлхий дахинд гепатит Б халдвар авсан олон сая хүмүүс байдаг боловч тэдний ихэнх нь халдвар авснаа мэддэггүй. Тэдэнд ямарваа нэгэн халдварын шинж тэмдэг илэрдэггүй, гэсэн хэдий ч зайлшгүй мэдэх ёстой олон зүйл байдаг. Гепатит Б-г оношлуулснаар та амьдралаа аварч чадна. Хэрвээ та гепатит Б вирустай гэдгээ мэдэж байвал та өөрийн элгийг эрүүл байлгах амьдралын хэв маягийг сонгож болох ба эмчид үзүүлж вирус таны элгийг гэмтээхээс сэргийлэх боломжтой. Гепатит Б Сан нь үндэсний ашгийн бус байгууллага бөгөөд судалгаа шинжилгээ, эрүүл мэндийн боловсрол болон зөвлөгөө мэдээллээр дамжуулан дэлхий дахинаа гепатит Б-ээр халдварласан олон сая хүмүүсийн амьдрах чадварыг дээшлүүлэх, эмчлэх арга замыг хайхад нь туслахад чиглэсэн байгууллага юм. Тайлбар: Тус вэбсайтын мэдээллүүд нь зөвхөн эрүүл мэндийн боловсрол олгох зорилготой. Гепатит Б Сан нь эрүүл мэндийн байгууллага биш болно. Та өөрийн эрүүл мэнд болон эмчилгээний талаар эмчтэйгээ зөвлөлдөж зөвлөгөө авна уу. Welcome to the Mongolian Chapter of the Hepatitis B Foundation Website Hepatitis B is known as a silent disease, and most people don’t even know they are infected. This website contains information about preventing, diagnosing and managing hepatitis B. We encourage you to share this information with your friends, family and others in your community. Here are some important things to remember about hepatitis B: Hepatitis B is not inherited - it is caused by a virus. 
 There is a safe vaccine which will protect you from hepatitis B for life. 
 There is a simple blood test to diagnose hepatitis B. 
 There are treatment options. Hepatitis B is a Global DiseaseHepatitis B can infect any person of any age or ethnicity, but people from parts of the world where hepatitis B is common, such as Asia, parts of Africa and South America, Eastern Europe, and the Middle East, are at much higher risk for getting infected. Hepatitis B is also common among Americans who were born (or whose parents were born) in these regions. There are hundreds of millions of people worldwide who have hepatitis B. Most people don’t even know they are infected, and don’t have symptoms – but there are many important things you should know. Getting tested for hepatitis B can save your life. If you know you have hepatitis B, you can make lifestyle choices to keep your liver healthy and you can see a doctor to help manage the virus and prevent liver damage. The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure and helping to improve the quality of life for all those affected by hepatitis B worldwide through research, education and patient advocacy. Disclaimer: The information that is provided on this website is for educational purposes only. The Hepatitis B Foundation is not a medical organization. Please talk to your doctor or a qualified health care provider for personal medical care and advice.

    https://www.hepb.org/languages/mongolian/
  • Board of Directors & Staff

    LEADERSHIP Chari A. Cohen, DrPH, MPH (bio)President Louis P. Kassa, III, MPA (bio)Chief Executive Officer Robert Gish, MD (bio)Medical Director Su Wang, MD, MPH, FACPSenior Advisor for Global Health Robert Christmas (bio)Chief Operating Officer Jean Holmes, MBA (bio)Vice President, Institutional Advancement Edward F. Tate III, MS (bio)Director, Communications & Marketing BOARD OFFICERS Timothy M. Block, PhDCo-founder and Chair  Louis P. Kassa, III, MPAChief Executive Officer Chari A. Cohen, DrPH, MPHPresident Catharine Williams, MGAVice Chair Joel Rosen, EsqVice Chair Elizabeth "Betsy" Seeber, MBA, CPA, FHFMATreasurer Wayne YetterSecretary Board of Directors Timothy M. Block, PhD, (bio)Co-founder and Chair  Stanley BroadbentRetired Managing Director, The Glenmede Trust Carol Brosgart, MDClinical Prof. of Medicine, UC San Francisco Nathaniel Brown, MDRetired biotech/pharma executive (focus on HBV and HCV) Chari A. Cohen, DrPH, MPHPresident, Hepatitis B Foundation  Loren Danzis, EsqPartner, Fox Rothschild LLP Craig Esterly, MBACo-founder and managing memberSD Asset Group Anthony Ford-Hutchinson, PhDFormer senior VP, vaccine researchMerck & Co. David A. Gruber, CPAOwner, Gruber Administrative Services, LLC Raman KapurChairman, Transition Patient Services, LLC Louis P. Kassa III, MPACEO, Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC); President of the PABC Mark PettyOperating Partner, Tinicum, LP Lewis Roberts, MB, ChB, PhDProfessor of Medicine, Mayo Clinic Joel Rosen, EsqVice Chair EmeritusManaging PartnerHigh Swartz Attorneys at Law Betsy Seeber, MBA, CPA, FHFMAVice President and Chief Financial OfficerDoylestown Health Thomas Shenk, PhDElkins Professor, Dept. of Molecular BiologyPrinceton University Elizabeth D. Sigety, EsqPartner, Fox Rothschild LLP  Walter Tsou, MD, MPHAdjunct Professor, University of PennsylvaniaFormer City Health Commissioner of Philadelphia Su Wang, MD, MPH, FACPMedical Director, Center for Asian HealthCatharine Williams, MGAVice Chair Wayne YetterFounding CEO of Astra Merck and Novartis (USA)   Scientific and Medical Advisors Harvey Alter, MD Nobel LaureateFormer Chief, Infectious Disease Section, Transfusion Medicine, National Institutes of Health Timothy M. Block, PhD Co-Founder and President, Hepatitis B Foundation and Baruch S. Blumberg Institute Nathaniel Brown, MDRetired Biotech/Pharma Executive (focus on HBV and HCV), San Francisco Carol Brosgart, MDClinical Professor of Medicine, Division of Global Health, UC San Francisco Francis Chisari, MDNational Academy of SciencesNational Academy of MedicineProfessor EmeritusScripps Research Institute Raymond Dwek, DPhil, FRSProfessor and Founder, Glycobiology Institute at the University of Oxford, Oxford, UK Anthony Ford-Hutchinson, PhDFormer Merck Sr. VP, Vaccine Research Lawrence Friedman, MDGastroenterologist, Massachusetts General Hospital Don Ganem, MDProfessor Emeritus, UC San Francisco Robert G. Gish, MDMedical director, Hepatitis B Foundation, and principal, Robert G Gish Consulting LLC Hie-Won L. Hann, MDProfessor and director, Liver Disease Prevention Center, Thomas Jefferson University Hospital, Philadelphia Anna Lok, MDAlice Lohrman Andrews Research Professor of Hepatology, Director of Clinical Hepatology, Assistant Dean for Clinical Research, University of Michigan Brian McMahon, MDScientific and Clinical Director, Liver Disease and Hepatitis Program, Alaska Native Medical Center, Fairbanks, AK Edith Mitchell, MDProgram Leader, GI OncologyDirector, Center to Eliminate Cancer DisparitiesClinical Professor, Jefferson University Robert Perrillo, MDSenior Research Hepatologist, Hepatology Division of Baylor University Medical Center, Dallas, and Adjunct Professor of Medicine, University of Texas Southwestern  Lewis Roberts, MB, ChB, PhDProfessor of Medicine, Mayo Clinic Kenneth Rothstein, MDDirector of Regional Outreach and Regional HepatologyProfessor of Clinical MedicinePenn Medicine Raymond Schinazi, PhDProfessor, Pediatrics and Chemistry, and Director of the Laboratory of Biochemical Pharmacology, Emory University; Founder of RFS Pharma Thomas Shenk, PhDElkins Professor, Dept. of Molecular Biology, Princeton University John Tavis, PhDProfessor, Molecular Microbiology and ImmunologySaint Louis University School of Medicine Norah Terrault, MDProfessor, Chief of Gastroenterology and Liver Diseases, University of Southern California Scientific and Medical Advisory Board Members Emeritus Stephen Locarnini, MD, PhD Board Members Emeritus Joan Block, RN, BSN Alan Brownstein, MPH Joseph Hediger Janine Witte   Honorary Board Members Anne Blumberg Jane Blumberg   In Memoriam Baruch Blumberg, MD, DPhilNobel LaureateDistinguished Scholar of the Hepatitis B Foundation (2011) W. Thomas London, MDEmeritus, Fox Chase Cancer Center (2017) William Mason, PhDEmeritus, Fox Chase Cancer Center (2022) Bud Tennant, DVMCollege of Veterinary Medicine, Cornell University (2016)  Paul WitteCo-Founder (2021)   HEPATITIS B FOUNDATION Chari A. Cohen, DrPH, MPH President Su Wang, MD, MPH, FACPSenior Advisor for Global Health Jean Holmes, MBAVice President, Institutional Advancement Monique BenvenuttiSocial Media and Communications Manager Maura Delaney Development Associate  Catherine Freeland, MPH, PhD Associate Director, Public Health Research Florence Gune, MPH, MPAPublic Health Program Coordinator Frank HoodAssociate Director, Policy and Partnerships and Director, Hep B United  Yasmin Ibrahim, MD, PhD, MBASenior Program Manager, Public Health Michaela Jackson, MSProgram Director, Prevention Policy Maureen KamischkePatient Engagement and Consult Specialist Shreya KoiralaProgram Coordinator, Public Health  Megan Pierce, CMPDirector of Events Anousha QureshiProgram Coordinator, Public Health Rhea Racho, MPAProgram Director, Advocacy & Engagement Kara Sapp, MS, MPHPublic Health Program Coordinator Alaina SchukraftDevelopment Manager Edward F. Tate III, MSDirector, Communications & Marketing Beatrice Zovich, MPHProgram Manager, Public Health BLUMBERG INSTITUTE STAFF

    https://www.hepb.org/about-us/board-of-directors-and-staff/